Charles River Laboratories International, Inc. (CRL)
345.37
+5.71
(+1.68%)
USD |
NYSE |
Oct 23, 16:00
345.15
-0.22
(-0.06%)
After-Hours: 20:00
Charles River Laboratories International Market Cap : 16.48B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 16.48B |
| October 22, 2026 | 16.21B |
| October 21, 2026 | 16.46B |
| October 20, 2026 | 15.06B |
| October 19, 2026 | 14.32B |
| October 16, 2026 | 14.33B |
| October 15, 2026 | 14.62B |
| October 14, 2026 | 14.41B |
| October 13, 2026 | 14.27B |
| October 12, 2026 | 14.41B |
| October 09, 2026 | 14.40B |
| October 08, 2026 | 14.22B |
| October 07, 2026 | 14.33B |
| October 06, 2026 | 14.56B |
| October 05, 2026 | 14.83B |
| October 02, 2026 | 13.85B |
| October 01, 2026 | 13.69B |
| September 30, 2026 | 14.08B |
| September 29, 2026 | 14.13B |
| September 28, 2026 | 14.06B |
| September 25, 2026 | 13.98B |
| September 24, 2026 | 14.05B |
| September 23, 2026 | 13.24B |
| September 22, 2026 | 13.61B |
| September 21, 2026 | 13.32B |
| Date | Value |
|---|---|
| September 18, 2026 | 13.27B |
| September 17, 2026 | 13.44B |
| September 16, 2026 | 13.05B |
| September 15, 2026 | 13.02B |
| September 14, 2026 | 13.03B |
| September 11, 2026 | 13.28B |
| September 10, 2026 | 13.03B |
| September 09, 2026 | 13.29B |
| September 08, 2026 | 13.40B |
| September 04, 2026 | 13.77B |
| September 03, 2026 | 14.00B |
| September 02, 2026 | 13.93B |
| September 01, 2026 | 13.48B |
| August 31, 2026 | 13.76B |
| August 28, 2026 | 13.91B |
| August 27, 2026 | 14.15B |
| August 26, 2026 | 14.08B |
| August 25, 2026 | 14.21B |
| August 24, 2026 | 14.25B |
| August 21, 2026 | 14.09B |
| August 20, 2026 | 13.91B |
| August 19, 2026 | 13.84B |
| August 18, 2026 | 13.33B |
| August 17, 2026 | 13.68B |
| August 14, 2026 | 13.37B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Fortrea Holdings, Inc. | 2.247B |
| IQVIA Holdings, Inc. | 45.98B |
| Medpace Holdings, Inc. | 18.67B |
| Champions Oncology, Inc. | 65.70M |
| Avantor, Inc. | 11.70B |
Market Cap Related Metrics
| PS Ratio | 4.224 |
| PEG Ratio | -0.2673 |
| Price to Book Value | 5.805 |
| Price to Free Cash Flow | 45.57 |
| Price | 345.37 |
| Earnings Yield | -1.40% |
| PEGY Ratio | -0.2673 |
| Operating PE Ratio | 31.25 |
| Normalized PE Ratio | 183.56 |